Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
Clobetasol, a super-high-potency topical steroid, can cause skin thinning (atrophy), stretch marks, and visible blood vessels, and while mild thinning often improves within weeks to months after stopping, striae and some atrophic changes may be permanent. Because clobetasol is absorbed through the skin, it can also suppress the hypothalamic-pituitary-adrenal axis, especially with use beyond 2 weeks, doses over roughly 50 g per week, application to large areas, thin skin like the face or groin, or use under occlusion or in children. HPA suppression is usually reversible once the medication is tapered or stopped, but abrupt discontinuation after prolonged use can trigger symptoms such as fatigue, nausea, dizziness, and low blood pressure. Risk depends heavily on potency, duration, body site, and whether the steroid is used in short bursts, so there are several important factors to consider below before assuming your changes are permanent. See the complete details below, including warning signs that warrant prompt medical evaluation.
If you are noticing thinning, shiny or crepey skin, new stretch marks, easy bruising, worsening rashes, or symptoms like unusual fatigue and lightheadedness while using or after stopping clobetasol, it helps to sort out whether you are dealing with a local skin effect, steroid withdrawal, or something unrelated. A free, instant, online symptom check can help you organize your symptoms, medication history, and timeline in a few minutes, then point you toward the right type of care, whether that is a dermatologist, your prescriber, or urgent evaluation. Understanding the likely cause early makes it easier to ask the right questions and avoid stopping a steroid abruptly on your own.
Last reviewed for medical accuracy: 09/14/2026
Clobetasol propionate is a very high-potency topical corticosteroid often prescribed for inflammatory skin conditions such as:
It works by reducing inflammation, itching and redness. Because it’s one of the strongest topical steroids available, it’s usually limited to short-term use or applied to small areas.
Topical corticosteroids like clobetasol can interfere with the normal production of collagen and the structure of the skin when used improperly or for too long. This can lead to:
In most cases, mild to moderate skin thinning improves after you stop using clobetasol. However, if skin has been treated:
…changes can be more pronounced and, in rare cases, long-lasting.
Your body naturally produces cortisol in the adrenal glands. Strong topical steroids can be absorbed through the skin and, in high enough amounts, trick your body into reducing its own cortisol production. This is called hypothalamic-pituitary-adrenal (HPA) axis suppression.
Mild suppression often shows no symptoms. More significant suppression can lead to:
Severe cases may progress to adrenal insufficiency, which can be life threatening if untreated.
Kids have a larger skin-to-body ratio, so they absorb proportionally more steroid. Extra caution is needed.
To minimize risk:
Clobetasol can be extremely effective at controlling severe flare-ups of inflammatory skin disorders. When used responsibly:
By following best practices—using the lowest potency, limiting duration and avoiding occlusion—you can greatly reduce the chance of lasting side effects.
Contact a healthcare professional right away if you experience:
These could be signs of serious adrenal insufficiency or complications requiring prompt care.
Always discuss any worries about clobetasol or other medications with your healthcare provider to ensure you’re using them safely and effectively.
(References)
* Korting HC, Vieluf D, Kerscher M. 0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream. Eur J Clin Pharmacol. 1992;42(2):159-61. doi: 10.1007/BF00278477. PMID: 1618247.
* Lubach D, Rath J, Kietzmann M. Skin atrophy induced by initial continuous topical application of clobetasol followed by intermittent application. Dermatology. 1995;190(1):51-5. doi: 10.1159/000246635. PMID: 7894098.
* Druce M, Goldstone AP, Tan TM, Meeran K. The pursuit of beauty. Lancet. 2008 Feb 16;371(9612):596. doi: 10.1016/S0140-6736(08)60272-X. PMID: 18280330.
* Pels R, Sterry W, Lademann J. Clobetasol propionate--where, when, why? Drugs Today (Barc). 2008 Jul;44(7):547-57. doi: 10.1358/dot.2008.44.7.1122221. PMID: 18806904.
* Sattar H, Manzoor J, Mirza L, Sheikh AM, Butt TA. Iatrogenic Cushing's syndrome in children presenting at Children's Hospital Lahore using nappy rash ointments. J Pak Med Assoc. 2015 May;65(5):463-6. PMID: 26028377.
* Saleem MD, Feldman SR. Desoximetasone 0.25% spray, adrenal suppression and efficacy in extensive plaque psoriasis. J Dermatolog Treat. 2018 Feb;29(1):36-38. doi: 10.1080/09546634.2017.1329508. Epub 2017 May 31. PMID: 28494626.
* Sasso O, Summa M, Armirotti A, Pontis S, De Mei C, Piomelli D. The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis. J Invest Dermatol. 2018 Mar;138(3):562-569. doi: 10.1016/j.jid.2017.07.853. Epub 2017 Oct 18. PMID: 29054595.
* Gonzalez-Moles MA, Bravo M, Gonzalez-Ruiz L, Ramos P, Gil-Montoya JA. Outcomes of oral lichen planus and oral lichenoid lesions treated with topical corticosteroid. Oral Dis. 2018 May;24(4):573-579. doi: 10.1111/odi.12803. Epub 2018 Feb 13. PMID: 29121431.
* Bertholle-Gil J, Gil-Palmer A, Nicolau-Ramis J. Adrenal insufficiency secondary to topic clobetasol. Med Clin (Barc). 2020 Apr 24;154(8):324-325. doi: 10.1016/j.medcli.2019.03.026. Epub 2019 May 31. PMID: 31160043.
* Einarsdottir MJ, Bankvall M, Robledo-Sierra J, Rödström PO, Bergthorsdottir R, Trimpou P, Hasséus B, Ragnarsson O. Topical clobetasol treatment for oral lichen planus can cause adrenal insufficiency. Oral Dis. 2024 Apr;30(3):1304-1312. doi: 10.1111/odi.14588. Epub 2023 Apr 27. PMID: 37103329.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.